Market Overview:
The global polyethylene glycol (PEG) in medical market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for PEG in various applications such as tablets, capsules, liquids, injectables, topicals and others. Additionally, the growing awareness about the benefits of PEG is also propelling the growth of this market. Some of the major players operating in this market are BASF SE (Germany), DowDuPont Inc. (U.S.), Evonik Industries AG (Germany), Huntsman Corporation (U.S.), INEOS Group Holdings S.A.(Switzerland), LyondellBasell Industries N.V.(Netherlands) and Solvay SA(Belgium).
Product Definition:
Polyethylene glycol (PEG) is a synthetic polymer in the form of a white, odorless, and tasteless powder. PEG is soluble in water and alcohol, but insoluble in ether. It is used as an emulsifier, thickener, solvent, and humectant.
Mw (<1000):
Mw stands for Molecular Weight and it is a unit to measure the molecular weight of a compound. It helps in determining the boiling point of compounds, which has significant importance in PEG (Polyethylene Glycol) industry. Mw value can be used as an indicator to monitor changes in PEG over time, since it reflects its molecular weight and purity.
Mw (1000-10000):
Mw 1000-10000 is the molecular weight range which is used to measure PEG.
Molecular Weight (MW) of Polyethylene Glycol (PEG) Is an important factor while selecting a particular product in medical industry, pharmaceuticals & chemical industries.
Application Insights:
Tablets were the largest application segment and accounted for a market share of more than 40% in 2017. PEG is widely used in manufacturing tablets, owing to its solubility property to dissolve in water and fat. It is also used as an active pharmaceutical ingredient (API) either alone or along with excipients such as diclofenac, aspirin, caffeine, simvastatin and others. The growing demand for low-calorie diet pills has been driving the polyethylene glycol market over the past few years. Moreover, increasing awareness about weight loss among consumers across various regions will further boost industry growth during the forecast period.
Capsules are expected to be one of fastest growing application segments during forecast years due to their high viscosity nature that makes them suitable for use with API's such as digoxin.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a growth rate of 5.6% over the forecast period owing to increasing R&D activities and high healthcare expenditure in U.S., which is one of the major drivers for PEG-based products demand.
Asia Pacific is anticipated to be one of fastest-growing regions during the forecast years due to factors such as improving healthcare infrastructure.
The key players operating in this region are Asian Polyethylene Glycol (APEG) Co., Ltd.; Nippon Polyethylene Glycol (NPEK), Inc.; Mitsubishi Chemical Holdings Corporation; Shinku Chemical Industry Co., Ltd.; SINOPEC; China Petrochemical Corp.
Growth Factors:
- Increasing demand for minimally invasive surgeries: Polyethylene glycol is increasingly being used as a lubricant in minimally invasive surgeries. This is because it does not cause any tissue damage and helps in smooth movement of surgical instruments inside the body cavity.
- Rising prevalence of chronic diseases: The global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is rising rapidly. This has led to an increase in the demand for PEG-based medical products and devices that can help in the treatment of these conditions.
- Growing use of PEG-based drugs for targeted drug delivery: Polyethylene glycol is being increasingly used to develop targeted drug delivery systems owing to its ability to penetrate cell membranes easily. This helps improve the efficacy and safety profile of drugs by reducing their systemic exposure levels.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polyethylene Glycol (PEG) in Medical Market Research Report
By Type
Mw (<1000), Mw (1000-10000)
By Application
Tablets, Capsules, Liquids, Injectables, Topicals, Others
By Companies
BASF, Dow Chemical, Croda, Clariant, Ineos, India Glycols, Shandong Ruisheng, Jiangxi Yipusheng, Liaoning Huaxing Chemical, Petronas Chemicals, BASF
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Polyethylene Glycol (PEG) in Medical Market Report Segments:
The global Polyethylene Glycol (PEG) in Medical market is segmented on the basis of:
Types
Mw (<1000), Mw (1000-10000)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablets, Capsules, Liquids, Injectables, Topicals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BASF
- Dow Chemical
- Croda
- Clariant
- Ineos
- India Glycols
- Shandong Ruisheng
- Jiangxi Yipusheng
- Liaoning Huaxing Chemical
- Petronas Chemicals
- BASF
Highlights of The Polyethylene Glycol (PEG) in Medical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mw (<1000)
- Mw (1000-10000)
- By Application:
- Tablets
- Capsules
- Liquids
- Injectables
- Topicals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polyethylene Glycol (PEG) in Medical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polyethylene glycol is a type of molecule that is often used in medical treatments. It can help to improve the effectiveness of drugs and other treatments by helping them to cross into cells more easily.
Some of the key players operating in the polyethylene glycol (peg) in medical market are BASF, Dow Chemical, Croda, Clariant, Ineos, India Glycols, Shandong Ruisheng, Jiangxi Yipusheng, Liaoning Huaxing Chemical, Petronas Chemicals, BASF.
The polyethylene glycol (peg) in medical market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polyethylene Glycol (PEG) in Medical Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Polyethylene Glycol (PEG) in Medical Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Polyethylene Glycol (PEG) in Medical Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Polyethylene Glycol (PEG) in Medical Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Polyethylene Glycol (PEG) in Medical Market Size & Forecast, 2018-2028 4.5.1 Polyethylene Glycol (PEG) in Medical Market Size and Y-o-Y Growth 4.5.2 Polyethylene Glycol (PEG) in Medical Market Absolute $ Opportunity
Chapter 5 Global Polyethylene Glycol (PEG) in Medical Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Polyethylene Glycol (PEG) in Medical Market Size Forecast by Type
5.2.1 Mw (<1000)
5.2.2 Mw (1000-10000)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Polyethylene Glycol (PEG) in Medical Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Polyethylene Glycol (PEG) in Medical Market Size Forecast by Applications
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Liquids
6.2.4 Injectables
6.2.5 Topicals
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polyethylene Glycol (PEG) in Medical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polyethylene Glycol (PEG) in Medical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Polyethylene Glycol (PEG) in Medical Analysis and Forecast
9.1 Introduction
9.2 North America Polyethylene Glycol (PEG) in Medical Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Polyethylene Glycol (PEG) in Medical Market Size Forecast by Type
9.6.1 Mw (<1000)
9.6.2 Mw (1000-10000)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Polyethylene Glycol (PEG) in Medical Market Size Forecast by Applications
9.10.1 Tablets
9.10.2 Capsules
9.10.3 Liquids
9.10.4 Injectables
9.10.5 Topicals
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Polyethylene Glycol (PEG) in Medical Analysis and Forecast
10.1 Introduction
10.2 Europe Polyethylene Glycol (PEG) in Medical Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Polyethylene Glycol (PEG) in Medical Market Size Forecast by Type
10.6.1 Mw (<1000)
10.6.2 Mw (1000-10000)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Polyethylene Glycol (PEG) in Medical Market Size Forecast by Applications
10.10.1 Tablets
10.10.2 Capsules
10.10.3 Liquids
10.10.4 Injectables
10.10.5 Topicals
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Polyethylene Glycol (PEG) in Medical Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Polyethylene Glycol (PEG) in Medical Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Polyethylene Glycol (PEG) in Medical Market Size Forecast by Type
11.6.1 Mw (<1000)
11.6.2 Mw (1000-10000)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Polyethylene Glycol (PEG) in Medical Market Size Forecast by Applications
11.10.1 Tablets
11.10.2 Capsules
11.10.3 Liquids
11.10.4 Injectables
11.10.5 Topicals
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Polyethylene Glycol (PEG) in Medical Analysis and Forecast
12.1 Introduction
12.2 Latin America Polyethylene Glycol (PEG) in Medical Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Polyethylene Glycol (PEG) in Medical Market Size Forecast by Type
12.6.1 Mw (<1000)
12.6.2 Mw (1000-10000)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Polyethylene Glycol (PEG) in Medical Market Size Forecast by Applications
12.10.1 Tablets
12.10.2 Capsules
12.10.3 Liquids
12.10.4 Injectables
12.10.5 Topicals
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Polyethylene Glycol (PEG) in Medical Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Polyethylene Glycol (PEG) in Medical Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Polyethylene Glycol (PEG) in Medical Market Size Forecast by Type
13.6.1 Mw (<1000)
13.6.2 Mw (1000-10000)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Polyethylene Glycol (PEG) in Medical Market Size Forecast by Applications
13.10.1 Tablets
13.10.2 Capsules
13.10.3 Liquids
13.10.4 Injectables
13.10.5 Topicals
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polyethylene Glycol (PEG) in Medical Market: Competitive Dashboard
14.2 Global Polyethylene Glycol (PEG) in Medical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BASF
14.3.2 Dow Chemical
14.3.3 Croda
14.3.4 Clariant
14.3.5 Ineos
14.3.6 India Glycols
14.3.7 Shandong Ruisheng
14.3.8 Jiangxi Yipusheng
14.3.9 Liaoning Huaxing Chemical
14.3.10 Petronas Chemicals
14.3.11 BASF